| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2023/02/09 | 07 : 17 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:AYLA | Ayala Pharmaceuticals Inc |
| 2023/02/07 | 04 : 50 | Edgar (US Regulatory) | Schedule 13g
(sc 13g/a) | NASDAQ:AYLA | Ayala Pharmaceuticals Inc |
| 2023/01/26 | 06 : 54 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AYLA | Ayala Pharmaceuticals Inc |
| 2023/01/25 | 00 : 22 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AYLA | Ayala Pharmaceuticals Inc |
| 2023/01/24 | 20 : 07 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:AYLA | Ayala Pharmaceuticals Inc |
| 2023/01/24 | 20 : 07 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:AYLA | Ayala Pharmaceuticals Inc |
| 2023/01/20 | 05 : 52 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:AYLA | Ayala Pharmaceuticals Inc |
| 2023/01/20 | 05 : 44 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:AYLA | Ayala Pharmaceuticals Inc |
| 2023/01/20 | 05 : 43 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:AYLA | Ayala Pharmaceuticals Inc |
| 2023/01/20 | 05 : 33 | Edgar (US Regulatory) | Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse) | NASDAQ:AYLA | Ayala Pharmaceuticals Inc |
| 2023/01/14 | 06 : 02 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AYLA | Ayala Pharmaceuticals Inc |
| 2023/01/05 | 07 : 04 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AYLA | Ayala Pharmaceuticals Inc |
| 2022/11/24 | 06 : 04 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AYLA | Ayala Pharmaceuticals Inc |
| 2022/11/18 | 06 : 36 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AYLA | Ayala Pharmaceuticals Inc |
| 2022/11/05 | 05 : 38 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:AYLA | Ayala Pharmaceuticals Inc |
| 2022/11/04 | 05 : 08 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:AYLA | Ayala Pharmaceuticals Inc |
| 2022/10/20 | 06 : 11 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:AYLA | Ayala Pharmaceuticals Inc |
| 2022/10/20 | 06 : 07 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AYLA | Ayala Pharmaceuticals Inc |
| 2022/10/11 | 17 : 46 | TipRanks | H.C. Wainwright Reaffirms Their Buy Rating on Ayala Pharmaceuticals (AYLA) | NASDAQ:AYLA | Ayala Pharmaceuticals Inc |
| 2022/10/11 | 17 : 45 | TipRanks | Noble Financial Reaffirms Their Hold Rating on Ayala Pharmaceuticals (AYLA) | NASDAQ:AYLA | Ayala Pharmaceuticals Inc |
| 2022/09/27 | 23 : 11 | TipRanks | Ayala Pharma (NASDAQ:AYLA) Bags fast Track Status for Desmoid Tumor Candidate | NASDAQ:AYLA | Ayala Pharmaceuticals Inc |
| 2022/09/27 | 21 : 58 | Dow Jones News | Ayala Pharmaceuticals Gets Fast-Track Designation for AL102 Cancer Treatment | NASDAQ:AYLA | Ayala Pharmaceuticals Inc |
| 2022/09/19 | 19 : 25 | TipRanks | H.C. Wainwright Sticks to Their Buy Rating for Ayala Pharmaceuticals (AYLA) | NASDAQ:AYLA | Ayala Pharmaceuticals Inc |
| 2022/09/13 | 21 : 05 | TipRanks | Ayala Pharmaceuticals (AYLA) Receives a Buy from Noble Financial | NASDAQ:AYLA | Ayala Pharmaceuticals Inc |
| 2022/09/12 | 21 : 16 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AYLA | Ayala Pharmaceuticals Inc |
| 2022/08/17 | 21 : 05 | TipRanks | Noble Financial Keeps Their Buy Rating on Ayala Pharmaceuticals (AYLA) | NASDAQ:AYLA | Ayala Pharmaceuticals Inc |
| 2022/08/17 | 05 : 40 | AllPennyStocks.com | Q2 Financial Results Send Micro Cap Soaring | NASDAQ:AYLA | Ayala Pharmaceuticals Inc |
| 2022/08/16 | 05 : 21 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:AYLA | Ayala Pharmaceuticals Inc |
| 2022/07/27 | 21 : 25 | TipRanks | Noble Financial Thinks Ayala Pharmaceuticals’ Stock is Going to Recover | NASDAQ:AYLA | Ayala Pharmaceuticals Inc |
| 2022/07/27 | 03 : 24 | TipRanks | Ayala Pharmaceuticals Stock Nearly Triples on Desmoid Tumor Treatment News | NASDAQ:AYLA | Ayala Pharmaceuticals Inc |
